Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
Home
Researchers
Research units
Research output
Search by expertise, name or affiliation
ARTS-based anticancer therapy: Taking aim at cancer stem cells
Ronit Elhasid,
Sarit Larisch
Department of Human Biology
Department of Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ARTS-based anticancer therapy: Taking aim at cancer stem cells'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticancer
50%
Anticancer Therapy
100%
Apoptosis
100%
Apoptosis-related Proteins
25%
Cancer Risk
25%
Cancer Stem Cells
100%
Cancer Types
25%
Cell-to-cell
25%
Cellular Targets
25%
Direct Binding
25%
Enhanced Resistance
25%
First-loss
25%
Gene-deficient Mice
25%
Human Patients
25%
In Vitro Study
25%
Induced Apoptosis
25%
Mouse Tumor Model
25%
Normal Stem Cells
100%
Patient Tumor
25%
Phenotypic Markers
25%
Poor Prognosis
25%
Pro-apoptotic
25%
Progenitor Cells
25%
Promote Apoptosis
50%
Septin
50%
Signaling Pathway
50%
Stem Cell Development
25%
Stem Cell Maintenance
25%
Stem Cell Targeting
25%
Stem Cells
50%
Stem number
25%
TGF Signaling
25%
Tumor Protein p53 (TP53)
25%
Tumor Risk
25%
Tumor Susceptibility
25%
Tumorigenesis
25%
Medicine and Dentistry
Cancer
12%
Cancer Risk
12%
Cancer Stem Cell
100%
Cancer Susceptibility
12%
Cancer Treatment
100%
Carcinogenesis
12%
Cell Maturation
12%
Cell Signaling Pathway
25%
In Vitro
12%
Malignant Neoplasm
62%
Neoplasm
12%
Normal Stem Cell
50%
Progenitor Cell
12%
Programmed Cell Death
100%
Septin
25%
Stem Cell
25%
Tumor Model
12%
Tumor Suppressor Protein
12%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Cancer Stem Cell
100%
Carcinogenesis
12%
Cell Maturation
12%
In Vitro Study
12%
Isoform
12%
Progenitor Cell
12%
Programmed Cell Death
100%
Septin
25%
Stem Cell
75%
Tumor Suppressor Protein
12%
X-Linked Inhibitory Apoptosis Protein
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Susceptibility
14%
Carcinogenesis
14%
Malignant Neoplasm
100%
Neoplasm
14%
Septin
28%
Tumor Model
14%
Tumor Suppressor Protein
14%